Patients have a stake in the relationship between doctors and pharmaceutical companies, so the CMA’s current review of its guidelines for doctor/pharma interactions is everybody’s business.
Academic rigor, journalistic flair
Articles on doctors ethics
Displaying all articles
At the moment there is too much left unsaid.
Doctors break no law in using a placebo, but may cross an ethical boundary in choosing not deceive a patient, or to facilitate a patient’s self-deception.
Top contributors
-
Lecturer, University of Wollongong
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
PhD candidate, School of Population Health Sciences, Bristol Medical School, University of Bristol
-
Associate professor, School of Public Policy and Administration, Carleton University
-
Assistant Professor (Status), University of Toronto
